Your browser doesn't support javascript.
loading
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
Lai, Yanzhen; Wang, Yu; Wu, Yaxian; Wu, Meng; Xing, Shan; Xie, Ying; Chen, Shulin; Li, Xiaohui; Zhang, Ao; He, Yi; Li, Huilan; Dai, Shuqin; Wang, Junye; Lin, Shudai; Bai, Yunmeng; Du, Hongli; Liu, Wanli.
Affiliation
  • Lai Y; Heyuan People's Hospital, Heyuan, China.
  • Wang Y; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu Y; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu M; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xing S; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xie Y; Heyuan People's Hospital, Heyuan, China.
  • Chen S; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li X; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang A; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • He Y; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li H; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Dai S; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang J; Department of Thoracic Surgery, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin S; School of Biology and Biological Engineering, 26467South China University of Technology, Guangzhou, China.
  • Bai Y; School of Biology and Biological Engineering, 26467South China University of Technology, Guangzhou, China.
  • Du H; School of Biology and Biological Engineering, 26467South China University of Technology, Guangzhou, China.
  • Liu W; Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Cancer Control ; 29: 10732748221104661, 2022.
Article de En | MEDLINE | ID: mdl-35653624

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Carcinome pulmonaire à petites cellules / Tumeurs du poumon Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites: Humans Langue: En Journal: Cancer Control Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Carcinome pulmonaire à petites cellules / Tumeurs du poumon Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites: Humans Langue: En Journal: Cancer Control Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique